Recursion Pharmaceuticals (RXRX) held about $557 million in cash at the end of its second quarter of 2026. Investors should ...

Recursion Pharmaceuticals RXRX continues to leverage its AI-native drug discovery platform through a broad portfolio of pharma, technology and data partnerships. These collaborations are expanding its ...

Recursion’s August business update highlighted that Genentech opted its first neuroscience target into an early discovery ...

A fact I recently learnedI recently finished reading a book on automata, and according to that book, Turing machines, lambda calculus, and recursive functions all have the same computational ...

Tempus AI Inc. stocks have been trading up by 6.55 percent after bullish coverage on its AI-driven healthcare data platform.

Linux commands often have long lists of options they support, many of which are single-letter mnemonics. These can be tricky ...

NYC City Council Speaker Julie Menin called OpenAI's Morgan Dwyer's answer to one question on safety "flippant, at best." ...

You have an AI write code. You have it check for errors and propose fixes. A human looks at the results and chooses what ...

Cathie Wood's ARK Invest executed a $22 million healthcare portfolio rotation on Monday, selling approximately $18 million of ...

A New Golden Age” receive such a warm reception, and thrilling to see the enthusiasm with which leaders from across government, industry, philanthropy, and the academy are stepping forward to ...